Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 8 studies | 34% ± 13% | |
adipocyte | 5 studies | 28% ± 17% | |
hepatocyte | 5 studies | 41% ± 23% | |
retinal pigment epithelial cell | 3 studies | 39% ± 14% | |
GABAergic neuron | 3 studies | 24% ± 2% | |
glutamatergic neuron | 3 studies | 27% ± 5% |
Insufficient scRNA-seq data for expression of CDO1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 2041.06 | 2608 / 2642 | 99% | 115.91 | 701 / 705 |
liver | 100% | 10858.23 | 226 / 226 | 89% | 223.69 | 362 / 406 |
adrenal gland | 90% | 1055.12 | 233 / 258 | 72% | 40.20 | 165 / 230 |
thymus | 89% | 904.42 | 582 / 653 | 53% | 17.10 | 319 / 605 |
breast | 99% | 3129.94 | 455 / 459 | 30% | 6.27 | 332 / 1118 |
prostate | 58% | 475.37 | 143 / 245 | 52% | 19.51 | 262 / 502 |
ovary | 97% | 1055.78 | 175 / 180 | 9% | 1.86 | 40 / 430 |
adipose | 99% | 3802.58 | 1195 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 2315.14 | 1265 / 1335 | 0% | 0 | 0 / 0 |
lung | 86% | 1009.82 | 499 / 578 | 7% | 1.13 | 77 / 1155 |
heart | 71% | 988.31 | 611 / 861 | 0% | 0 | 0 / 0 |
uterus | 61% | 462.02 | 104 / 170 | 8% | 2.53 | 37 / 459 |
pancreas | 25% | 131.26 | 81 / 328 | 44% | 9.08 | 78 / 178 |
bladder | 57% | 579.38 | 12 / 21 | 6% | 1.35 | 30 / 504 |
esophagus | 50% | 489.47 | 725 / 1445 | 5% | 1.93 | 9 / 183 |
intestine | 37% | 249.47 | 353 / 966 | 5% | 1.40 | 24 / 527 |
muscle | 39% | 329.35 | 310 / 803 | 0% | 0 | 0 / 0 |
stomach | 28% | 259.63 | 101 / 359 | 7% | 1.20 | 19 / 286 |
eye | 0% | 0 | 0 / 0 | 31% | 7.04 | 25 / 80 |
skin | 16% | 107.49 | 293 / 1809 | 10% | 2.67 | 49 / 472 |
kidney | 18% | 118.74 | 16 / 89 | 8% | 2.07 | 69 / 901 |
lymph node | 0% | 0 | 0 / 0 | 10% | 2.25 | 3 / 29 |
spleen | 5% | 35.51 | 13 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 11.73 | 11 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007595 | Biological process | lactation |
GO_0019448 | Biological process | L-cysteine catabolic process |
GO_0051591 | Biological process | response to cAMP |
GO_0043200 | Biological process | response to amino acid |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0033762 | Biological process | response to glucagon |
GO_0006954 | Biological process | inflammatory response |
GO_0042412 | Biological process | taurine biosynthetic process |
GO_0000097 | Biological process | sulfur amino acid biosynthetic process |
GO_0006534 | Biological process | cysteine metabolic process |
GO_0045471 | Biological process | response to ethanol |
GO_0005829 | Cellular component | cytosol |
GO_0016151 | Molecular function | nickel cation binding |
GO_0008198 | Molecular function | ferrous iron binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0017172 | Molecular function | cysteine dioxygenase activity |
Gene name | CDO1 |
Protein name | Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I) |
Synonyms | |
Description | FUNCTION: Catalyzes the oxidation of cysteine to cysteine sulfinic acid with addition of molecular dioxygen. . |
Accessions | Q16878 ENST00000250535.5 |